Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Goldman Sachs Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
William Blair on Sarepta Therapeutics (SRPT): 'we continue to view the stock’s near-term upside potential as limited'
-
Leerink Partners Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Marvell (MRVL)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Abbott Labs (ABT)
-
-
-
-
-
-
-
Waste Connections Inc. (WCN) PT Lowered to $202 at Scotiabank
-
-
-
-
-
-
-
iQIYI (IQ) PT Raised to $2.30 at Citi
-
-
-
-
-
-
-
Wells Fargo on Bath & Body Works Inc. (BBWI): 'Reiterate BBWI as a Top Pick'
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Lowered to $135 at Mizuho
-
-
-
-
-
424,404 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.